GATX vs CAI

For growth investors, Caris Life Sciences, Inc.

(CAI) is the stronger pick with 97. 0% revenue growth year-over-year, versus 12. 4% for GATX Corporation (GATX). GATX Corporation (GATX) offers the better valuation at 25. 1x trailing P/E (19. 5x forward), making it the more compelling value choice. Analysts rate GATX Corporation (GATX) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, GATX Corporation is actually cheaper at 19.

5x.

Over the past 5 years, GATX Corporation (GATX) delivered a total return of +105.

9%, compared to -32. 3% for Caris Life Sciences, Inc. (CAI). Over 10 years, the gap is even starker: GATX returned +389. 6% versus CAI's -32. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), GATX Corporation (GATX) is the lower-risk stock at 0.

71β versus Caris Life Sciences, Inc. 's 1. 60β — meaning CAI is approximately 126% more volatile than GATX relative to the S&P 500. On balance sheet safety, Caris Life Sciences, Inc. (CAI) carries a lower debt/equity ratio of 0% versus 3% for GATX Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Caris Life Sciences, Inc.

(CAI) is pulling ahead at 97. 0% versus 12. 4% for GATX Corporation (GATX). On earnings-per-share growth, the picture is similar: GATX Corporation grew EPS 9. 3% year-over-year, compared to -19. 3% for Caris Life Sciences, Inc.. Over a 3-year CAGR, CAI leads at 46. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

GATX Corporation (GATX) is the more profitable company, earning 17.

9% net margin versus -66. 2% for Caris Life Sciences, Inc. — meaning it keeps 17. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GATX leads at 29. 9% versus 5. 6% for CAI. At the gross margin level — before operating expenses — GATX leads at 48. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, GATX Corporation (GATX) trades at 19.

5x forward P/E versus 157. 3x for Caris Life Sciences, Inc. — 137. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CAI: 51. 7% to $28. 75.

In this comparison, GATX (1.

2% yield) pays a dividend. CAI does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, GATX Corporation (GATX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

71), 1. 2% yield, +389. 6% 10Y return). Caris Life Sciences, Inc. (CAI) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GATX: +389. 6%, CAI: -32. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (GATX (Industrials) and CAI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: GATX is a small-cap quality compounder stock; CAI is a mid-cap high-growth stock. GATX pays a dividend while CAI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.